492
Participants
Start Date
November 7, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Empagliflozin 10 MG
The intervention group will receive a 10 mg tablet of empagliflozin once a day from 3 days before surgery until discharge from the hospital.
Placebo
The comparator group will receive a matching placebo from 3 days before surgery until discharge from the hospital.
RECRUITING
Tehran Heart Center, Tehran
RECRUITING
Rajaie Cardiovascular Medical & Research Center, Tehran
Tehran Heart Center
OTHER
Rajaie Cardiovascular Medical and Research Center
OTHER